Real Brands To Acquire CBD Manufacturer Boulder Botanical

Real Brands Inc. RLBD has signed a letter of intent to acquire substantially all the assets of Boulder Botanicals & Biosciences Laboratories, Inc., a manufacturer of white-label and private-label CBD and non-CBD products. The acquisition will include Boulder Botanical’s brands, IP, distribution and 27,000 sq. ft. R&D and production facility in Golden, Colorado.

On April 22, 2022, Boulder Botanical became a subsidiary of Frankens Investment Fund, LLC. This proposed transaction remains subject to a definitive agreement and due diligence. A formal closing is expected within the next few weeks.

Highlights of Boulder Botanical’s facilities and capabilities include:

  • Original product development and research, consumer products, and fulfillment services for products distributed through some of the nation’s largest retail channels, including CVS CVS, Sam’s Club, Target TGT, Whole Foods, Safeway, Costco COST, 7-Eleven, and Circle K.

  • In-house brands that include APRA, SmartLeef, and dozens of white-label brands.

  • 25+ years of combined experience in consumer-packaged goods and compliance.

  • A full complement of certifications and registrations, including FDA-Registered Manufacturing/Distribution & Fulfilment, GMP quality assured, Certified Kosher Ingredient Supplier, CODPHE Licensed Manufacturing Facility, CO Dept of Ag Hemp Seed Seller and Grower License, International Cosmetic Ingredient Assignment Registration for supply Cosmetic Industry.

“The Boulder Botanical’s transaction will augment Real Brands’ existing portfolio of branded products and expand its distribution capabilities,” stated Thom Kidrin, president & CEO of Real Brands Inc. “This deal will bring 150 proprietary formulations to Real Brands, and the R&D capabilities to create hundreds more. In addition, it should enlarge Real Brands’ distribution channels as we shift from primarily online sales via Real Brands’ own website and small, regionalized distributors to an existing national network with ready access to millions of potential consumers. This outstanding opportunity should enable Real Brands to capture an even larger market share of the booming CBD market, which Vantage Market Research expects to grow to $47.2 billion by 2028.”

Photo by Tim Foster on Unsplash

Related News

Real Brands Enters Medical Psychedelics Market, Partners With Marcu & Arora For Licensure, R&D

Real Brands Expands Into EU Via Strategic Partnership With Hungary-Based Hemp Distributor

CBD Company Real Brands Uplists To OTCQB

Posted In: CannabisM&ANewsPenny StocksMarkets7-ElevenBoulder Botanicals & Biosciences LaboratoriesCircle KFrankens Investment Fund LLCInc.SafewaySam’s ClubThom KidrinWhole Foods
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...